During the last few years, BAP1 has gained a clinical interest as a critical tumor suppressor as its loss leads to induction of many cancers [15] including lung cancer, breast cancer, uveal melanoma, meningioma, pleural mesothelioma, and renal cell carcinoma [6,16–28]. This evidence concerns the gene BAP1 and neoplasm.